Supriya Announce Agreement To Market Plasma Nutrition’s IoProtein In India

Mumbai : API company Supriya Lifescience has announced a recent collaboration with Plasma Nutrition, a US-based nutrition company located in Delaware.

The strategic partnership involves an exclusive technology licensing agreement, granting Supriya Lifescience the sole rights for manufacturing and marketing Ingredient Optimised Protein (ioProtein) in India.

The primary purpose of this collaboration is to bring the optimised protein into the Indian market. ioProtein is a patented process (patent pending in the US) This revolutionary protein powder is designed for use as protein supplements and boasts a significant advantage, and it is highly bioavailable. This means that higher amounts of proteins are absorbed quickly by the body, providing consumers with a more effective and efficient protein supplement.

During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India. This marks the introduction of a new category of protein powders in the Indian market, and it is relatively healthier compared to other popular protein powders available through various gyms, general stores, and digital marketing channels.

“We are thrilled to be the exclusive partner of Plasma Nutrition, in introducing the innovative ioProtein to the Indian market,” said Dr Saloni Wagh, Executive Director at Supriya Lifescience.

“This strategic partnership represents our commitment to providing high-nutrition solutions to consumers in India. With ioProtein’s high bioavailability and its unmatched advantage, we are confident that the ‘IO’ technology will revolutionise the nutrition industry and become the preferred choice for health-conscious individuals,” Dr Wagh added.

“We are excited to collaborate with Supriya Lifescience and bring our patented ioProtein technology to India,” said Chris Flynn-Rozanski, co-founder & CEO at Plasma Nutrition.

“India’s rapidly growing demand for protein supplements present an excellent opportunity for us to introduce this highly bioavailable protein powder, which has already been well-received in other markets. We believe this partnership will create a new standard for protein supplementation in India,” Flynn-Rozanski said.

Related Posts

  • Pharma
  • July 26, 2024
  • 118 views
US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

  • Pharma
  • July 26, 2024
  • 108 views
Indian National Charged With Selling Counterfeit Cancer Drugs

HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

Indian National Charged With Selling Counterfeit Cancer Drugs

Indian National Charged With Selling Counterfeit Cancer Drugs

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

BIS Sanctioned 82 Medical Device Projects To Develop Standards

BIS Sanctioned 82 Medical Device Projects To Develop Standards

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD